Contact:
Axion BioSystems
1819 Peachtree St NE
Suite 350
Atlanta, GA 30309
United States of America
Phone: 404-477-2557
Founded: 2008, Atlanta, Georgia, USA
Founders: Tom O’Brien, Jim Ross, Kevin Gould
Website: www.axionbiosystems.com
Axion BioSystems is a leading biotechnology company that develops and commercializes advanced live-cell analysis platforms for use in biomedical research and drug discovery. Their core technologies, including multiwell microelectrode array (MEA) systems and impedance-based assays, enable real-time, label-free monitoring of cellular activity in vitro.
Originally founded to meet the growing demand for dynamic, high-throughput cell analysis, Axion’s platforms have become widely adopted in neuroscience, cardiotoxicity, oncology, and stem cell research. The company’s flagship Maestro systems are used globally by academic institutions, pharmaceutical companies, and CROs for applications such as neurotoxicity screening, cardiac safety profiling, and disease modeling.
Axion BioSystems continues to expand its portfolio through the development of AI-powered software tools and complementary assay kits, supporting a more complete understanding of complex cellular behaviors in 2D and 3D models.